TAKE A LOOK AT WHICH REPORT YOUR PORTFOLIO'S BEEN MISSING...

Shareholders Foundation offers real-time reporting of class action exposure on a per transaction basis,
including the documents you will need for claim filing and settlement recovery.
Start Monitoring Your Investments

ArQule, Inc. (NASDAQ:ARQL) Investor Investigation Over Possible Breaches Of Fiduciary Duties Announced

  • If you purchased shares of ArQule, Inc. (NASDAQ:ARQL), you have certain options and you should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this investigation, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Investigation Overview

Company
ArQule, Inc.
Security
NASDAQ: ARQL

Summary

An investigation on behalf of investors in shares of ArQule, Inc. (NASDAQ:ARQL) was announced over potential breaches of fiduciary duties by certain officers and directors at ArQule.

The investigation by a law firm concerns whether certain ArQule directors breached their fiduciary duties.

Burlington, MA based ArQule, Inc. is a biopharmaceutical company that is engaged in the research and development of therapeutics to treat cancers and rare diseases. ArQule, Inc. reported that its annual Total Revenue declined from $11.24 million in 2015 to $4.71 million in 2016 and that its Net Loss increased from $13.77 million in 2015 to $22.72 million in 2016.

Shares of ArQule, Inc. (NASDAQ:ARQL) declined in April 2017 to as low as $0.94 per share.

Start Monitoring Your Investments